Traders should monitor for imminent equity offerings, which are likely given the company's cash-intensive biotech profile and history of frequent dilutive financings. The market may price in dilution risk immediately, especially given the company's $4M market cap and pattern of capital raises.
Price Chart
Executive Summary
GeoVax Labs has had five separate registration statements (S-3) become effective, allowing the company to raise capital through future offerings of up to $200 million in aggregate. This creates a potential dilution overhang for shareholders as the company can now sell common stock, prefunded warrants, or other securities at any time over the next three years.
Key Facts
- Five S-3 registration statements (File Nos. 333-280040, 333-292127, 333-281973, 333-281972, 333-281310) became effective on April 17, 2026
- Total aggregate offering capacity is $200 million across all shelf registrations
- Securities may include common stock, prefunded warrants, or other equity-linked instruments
- No specific offering size, price, or timing was disclosed in these filings
- Company has a history of frequent capital raises via registered direct offerings and ATM programs
Financial Impact
Up to $200 million in potential dilution over time
Risk Factors
- Significant shareholder dilution from future offerings
- Downward pressure on stock price due to overhang effect
- Execution risk if offerings are priced at steep discounts
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 15 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (GOVX) — Batch item 1 | 9999999995-26-001227 |
| Document: 9999999995-26-001227-index.html | 9999999995-26-001237 |
| Document: 9999999995-26-001227.txt | 9999999995-26-001232 |
| EFFECT Filing (GOVX) — Batch item 4 | 9999999995-26-001237 |
| Document: 9999999995-26-001237-index.html | 9999999995-26-001230 |
| Document: 9999999995-26-001237.txt | 9999999995-26-001227 |
| EFFECT Filing (GOVX) — Batch item 7 | 9999999995-26-001232 |
| Document: 9999999995-26-001232-index.html | 9999999995-26-001227 |
| Document: 9999999995-26-001232.txt | 9999999995-26-001227 |
| EFFECT Filing (GOVX) — Batch item 10 | 9999999995-26-001231 |
| Document: 9999999995-26-001231-index.html | 9999999995-26-001227 |
| Document: 9999999995-26-001231.txt | 9999999995-26-001227 |
| EFFECT Filing (GOVX) — Batch item 13 | 9999999995-26-001230 |
| Document: 9999999995-26-001230-index.html | 9999999995-26-001227 |
| Document: 9999999995-26-001230.txt | 9999999995-26-001227 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 8-K | $0.2032 | awaiting T+60 | — | $0.2010 (+1.08%) |
Sep 24, 2026 4w ago | EFFECT | $0.3603 | awaiting T+60 | — | $0.2010 (+44.21%) |
Jun 4, 2026 20w ago | EFFECT | $1.79 $0.7210 | ▲ +59.72% | ▲ +61.60% | $0.2010 (+88.77%) |
May 26, 2026 22w ago | S-1 | $3.49 $0.5947 | ▼ −82.96% | ▼ −85.68% | $0.2010 (−94.24%) |
May 19, 2026 23w ago | 8-K | $2.23 $0.7180 | ▲ +67.80% | ▲ +72.81% | $0.2010 (+90.99%) |
May 14, 2026 23w ago | 8-K | $1.23 $0.7700 | ▲ +37.40% | ▲ +41.91% | $0.2010 (+83.66%) |
May 7, 2026 24w ago | 8-K | $1.67 $0.7620 | ▲ +54.37% | ▲ +59.21% | $0.2010 (+87.96%) |
Apr 22, 2026 27w ago | EFFECT | $1.17 $0.9742 | ▼ −16.73% | ▼ −21.51% | $0.2010 (−82.82%) |
Apr 20, 2026 27w ago | EFFECT | $1.17 $1.01 | ▲ +13.68% | ▲ +20.45% | $0.2010 (+82.82%) |
Apr 15, 2026 27w ago | 8-K | $1.23 $1.11 | ▲ +9.76% | ▲ +16.80% | $0.2010 (+83.66%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers